CMC Considerations for CAR T Cell Product Development

  Рет қаралды 12,408

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
36:56
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy
U.S. Food and Drug Administration
Рет қаралды 7 М.
Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
1:19:35
Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
U.S. Food and Drug Administration
Рет қаралды 28 М.
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
21:38
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
Я ОТ САКЕ
Рет қаралды 1,5 МЛН
Симбу закрыли дома?! 🔒 #симба #симбочка #арти
00:41
Симбу закрыли дома?! 🔒 #симба #симбочка #арти
Симбочка Пимпочка
Рет қаралды 5 МЛН
Creative Justice at the Checkout: Bananas and Eggs Showdown #shorts
00:18
Creative Justice at the Checkout: Bananas and Eggs Showdown #shorts
Fabiosa Best Lifehacks
Рет қаралды 28 МЛН
Уральские пельмени в Камеди 🥰 #ComedyClub #КамедиКлаб #овршоу #уральскиепельмени #тнт #харламов
00:58
Уральские пельмени в Камеди 🥰 #ComedyClub #КамедиКлаб #овршоу #уральскиепельмени #тнт #харламов
Comedy Club
Рет қаралды 7 МЛН
Panel Discussion
34:04
Panel Discussion
U.S. Food and Drug Administration
Рет қаралды 862
Designing First-In-Human Trials for Small Molecules and Biologics
37:34
Designing First-In-Human Trials for Small Molecules and Biologics
U.S. Food and Drug Administration
Рет қаралды 11 М.
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
28:11
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
U.S. Food and Drug Administration
Рет қаралды 12 М.
Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it.
1:02:19
Chemistry and Manufacturing Requirements for Early Clinical Development: What’s in there? Prove it.
U.S. Food and Drug Administration
Рет қаралды 11 М.
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
1:20:20
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
U.S. Food and Drug Administration
Рет қаралды 23 М.
77th Cellular, Tissue, and Gene Therapies Advisory Committee
5:59:50
77th Cellular, Tissue, and Gene Therapies Advisory Committee
U.S. Food and Drug Administration
Рет қаралды 3,9 М.
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
U.S. Food and Drug Administration
Рет қаралды 10 М.
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
44:31
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
U.S. Food and Drug Administration
Рет қаралды 12 М.
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
20:33
ICH M7(R1) - Chemistry and Manufacturing Control (CMC) Perspective on Hazard Assessment
U.S. Food and Drug Administration
Рет қаралды 7 М.
FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018
41:00
FDA Regulatory Requirements for Clinical Investigators and Case Examples (9of14) REdI 2018
U.S. Food and Drug Administration
Рет қаралды 4,1 М.
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
21:38
Я не из тех, кто ксивой машет - я скромный | Сериал «ПрАкурор» | 3 серия | КОНКУРС
Я ОТ САКЕ
Рет қаралды 1,5 МЛН